Becker's Hospital Review

ECG Adds STAMP, a Software Platform to Drive Customer Loyalty for Health Plans

Boston, MA—October 22, 2025: ECG Management Consultants, a leading consulting firm to health systems and payers, today announced the addition of STAMP, a SaaS-based platform that enables payers to ...

HeartBeam (NASDAQ: BEAT) Announces Commercial Partnership With ClearCardio

HeartBeam (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care through advanced cardiac ...
Yahoo

FDA clears HeartBeam’s at-home arrhythmia assessment tool

HeartBeam intends to initiate a limited launch of its ECG software device in Q1 2026. Image credit: YAKOBCHUK VIACHESLAV via Shutterstock.com. HeartBeam has secured US Food and Drug Administration ...
Business Wire

AccurKardia Delivers Its ECG Interpretation Software Within the Lucem Health Reveal Family of Clinical AI Solutions

NEW YORK--(BUSINESS WIRE)--AccurKardia, an ECG-led diagnostics software company, today announced a multi-year agreement with Lucem Health, a leading provider of clinical AI solutions. The partnership ...
Becker's Hospital Review

ECG software analytics company joins Innovators’ Network at American Heart Association

Electrocardiogram software analytics company AccurKardia is joining the Innovators’ Network at the American Heart Association Center for Health and Technology Innovation. The Innovator’s Network is a ...
Yahoo Finance

HeartBeam (BEAT) Secures FDA 510(k) Clearance for 12-Lead ECG Synthesis Software Following Successful Appeal

LOS ANGELES, CA - December 10, 2025 (NEWMEDIAWIRE) - HeartBeam (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care through personalized insights, received FDA 510(k) ...
Business Wire

Tempus Receives U.S. FDA 510(k) Clearance for Tempus ECG-Low EF Software

CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced it has received 510(k) ...
FierceBiotech

AccurKardia's automated ECG analysis software snags FDA nod

With cases of arrhythmia and heart disease on the rise—thanks in large part to an aging global population—more tools and technologies are needed to speed up the process of diagnosing and beginning ...
MarketWatch

AccurKardia Receives FDA Breakthrough Device Designation for First-of-its-Kind Aortic Valve Stenosis ECG-based AI Screening Software

AccurKardia, an innovator in ECG-based diagnostics technology, has announced that its Aortic Valve Stenosis (AVS) ECG-based AI screening software has been granted Breakthrough Device Designation by ...
MobiHealthNews

Russian entrepreneur Natalia Glazkova talks noise-canceling ECG software

Wearable data is becoming more integrated into clinical practice, but there is one caveat, explains Sense2beat CEO Natalia Glazkova — those devices can be contaminated by a glut of data. Sense2beat is ...
Nasdaq

CardioComm Solutions Secures Health Canada Clearance for Artificial Intelligence ECG Interpretation for Multiple Cardiac Arrhythmias

GEMS(TM) Rhythm AI Clearance will Address Event, Holter and Long-Term Continuous ECG Monitoring Needs for Remote Patient Monitoring in Canada The GEMS Rhythm arrhythmia and morphology abnormality AI ...
Morningstar

HeartBeam Provides Update on Regulatory Path Following FDA Decision on 12-Lead ECG Synthesis Software Application

Company engaging in multiple options for a constructive resolution Strategy is underpinned by a clinical study that achieved the agreed upon endpoints Company believes that labeling modifications can ...